• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • ConventionCALL FOR: Podium and Poster Abstracts

    For the 38th GAPNA Annual Conference
    at the Hyatt Regency
    New Orleans, LA, September 24-26, 2020

    GAPNA members are invited to submit an abstract about their innovative work, that should enrich the APRN's knowledge and/or enhance the care of an older adult.

    Find out more info and deadline dates

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Update in Chronic Kidney Disease Management and Prescribing"

    (session captured at the GAPNA 2018 Annual Conference)

    For January/February 2020 - Get Your Free CNE Now!

  • Online CEThe Best of 2019!

    A LIVE rebroadcast event featuring 5 of GAPNA's Best CE sessions from 2019

    January 21, 2020 from 11:30 am - 5:15 pm EST

    $39 for GAPNA Members $59 for Non-Members


    Register Now

Racial Disparities Shown in the Postsurgical Treatment of Elderly Women with Early-Stage Breast Cancer

Older Black women are less likely than older White women to receive chemotherapy or radiation therapy after having breast-conserving surgery (BCS) for early-stage breast cancer, according researchers.

Previously, racial disparities in breast cancer mortality were attributed to Black women being diagnosed when the cancer was at a later stage, fewer physician recommendations for breast cancer screening, higher rates of obesity and hypertension, as well as nonclinical factors.

Researchers compared post-surgical treatment of Black and White women aged 65 or older diagnosed with early-stage breast cancer, who were treated by either BCS or mastectomy, and had close-in (proximal) lymph nodes checked for the presence of cancer cells.

After adjusting their data for patient age, tumor characteristics, number of co-existing illnesses (and socioeconomic status in a second model), researchers found Black women were less likely than White women to receive chemotherapy (25% less if lymph node-positive and 17% less if node-negative).

To learn more, see Sail et al. (2012). Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Ethnicity & Health, 17(3), 309-323. doi:10.1080/13557858.2011.628011


Related Topic 1: 

GAPNA Newsletter Issue: